OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer
Janine Ziemons, Romy Aarnoutse, Anne Heuft, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3919-3933
Open Access | Times Cited: 8
Janine Ziemons, Romy Aarnoutse, Anne Heuft, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3919-3933
Open Access | Times Cited: 8
Showing 8 citing articles:
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
Masakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Masakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Gut Microbiota—Adversary or Ally? Its Role and Significance in Colorectal Cancer Pathogenesis, Progression, and Treatment
Katarzyna Chawrylak, Magdalena Leśniewska, Katarzyna Mielniczek, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2236-2236
Open Access | Times Cited: 4
Katarzyna Chawrylak, Magdalena Leśniewska, Katarzyna Mielniczek, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2236-2236
Open Access | Times Cited: 4
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma
Jiali Yao, Beifang Ning, Jin Ding
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Jiali Yao, Beifang Ning, Jin Ding
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon
Janine Ziemons, Lars E. Hillege, Romy Aarnoutse, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Janine Ziemons, Lars E. Hillege, Romy Aarnoutse, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?
Karolina Kaźmierczak-Siedlecka, Nikola Bulman, Paweł Ulasiński, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 3
Karolina Kaźmierczak-Siedlecka, Nikola Bulman, Paweł Ulasiński, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 3
Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon
Janine Ziemons, Lars E. Hillege, Romy Aarnoutse, et al.
Research Square (Research Square) (2024)
Open Access
Janine Ziemons, Lars E. Hillege, Romy Aarnoutse, et al.
Research Square (Research Square) (2024)
Open Access
Endoplasmic reticulum stress in intestinal microecology: A controller of antineoplastic drug-related cardiovascular toxicity
Jingyi Zhang, Xiaoya Li, De-Xiu Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117720-117720
Open Access
Jingyi Zhang, Xiaoya Li, De-Xiu Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117720-117720
Open Access
Metagenomic analysis during capecitabine therapy reveals microbial chemoprotective mechanisms and predicts drug toxicity in colorectal cancer patients
Lars E. Hillege, Kai Trepka, Janine Ziemons, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Lars E. Hillege, Kai Trepka, Janine Ziemons, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
